LCAR-BCDR Cells / Legend Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LCAR-BCDR Cells / Legend Biotech
NCT05376345: BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

Recruiting
1
32
RoW
LCAR-BCDR cells product
Weijun Fu, Nanjing Legend Biotech Co.
Relapsed/Refractory Multiple Myeloma
06/24
09/26

Download Options